Healthcare Enterprise Only

ArteraAI

Multimodal AI tests supporting personalized prostate cancer treatment decisions

Visit official website
PricingEnterprise Only
Starting priceContact sales
Free planUnknown
Free trialYes
APIUnknown
Open sourceNo
DeploymentClinical Workflow
Last verifiedAugust 2, 2026
Overview

Tool overview

ArteraAI is listed under Healthcare AI tools.

Summary

What is ArteraAI?

ArteraAI develops multimodal AI tests that analyze digital pathology images and patient data to provide prognostic and predictive insights for prostate cancer care. Its clinical reports support risk assessment and treatment discussions within qualified oncology workflows.

Best fit

Best for

Oncology teams using AI-supported prostate cancer treatment planning

Audience

Who is it for?

Radiation oncologistsUrologistsPathology teamsCancer-care organizations
Recommendation

Decision note

Accepted for Preview after independent V411 official-source research. Apply only after failures = 0, warnings = 0, unmapped = 0, and review of controlled fields, Arabic v2 parity, outreach, affiliate status, logo QA, rebrand handling, and explicit clears.

Capabilities

Key features

Multimodal pathology and clinical-data analysis

Prognostic and predictive prostate insights

Clinical reports for treatment planning

Support for qualified oncology workflows

Workflows

Use cases

Estimating prostate cancer risk

Supporting treatment-intensification decisions

Informing clinician-patient discussions

Adding AI insights to digital pathology

Strengths

Pros

  • Focused oncology decision-support use case
  • Published clinical and regulatory resources
  • Available through healthcare partnerships
Considerations

Cons

  • Public pricing is unavailable
  • Requires qualified clinical interpretation
  • Availability depends on test and region
Considerations

Limitations

ArteraAI reports support but do not replace clinician judgment, pathology review, or applicable medical guidelines. Performance and availability depend on the specific test, patient population, specimen quality, regulatory status, reimbursement, and local healthcare workflow.

Cost

Pricing details

Pricing modelEnterprise Only
Starting priceContact sales
Free planUnknown
Free trialYes
Pricing context

Billing options

Custom clinical test arrangement

Pricing context

Pricing note

ArteraAI does not publish self-service pricing. Test access, ordering, reimbursement, and commercial terms depend on the clinical indication, healthcare organization, geography, and partner channel. No ongoing public free plan or product trial was confirmed.

View official pricing
Compatibility

Supported languages

  • English
Specs

Technical details

PlatformsWeb
Multilingual supportUnknown
Login requiredUnknown
Open sourceNo
DeploymentClinical Workflow
CompanyArteraAI
Models / versionsMultimodal AI platform
Editions / plansArteraAI Prostate Test ArteraAI mHSPC Test
Data confidenceHigh
Last verifiedAugust 2, 2026
Documentation → Release notes → Data source →
Decision hub

Finish your evaluation of ArteraAI

Move between similar tools, comparison cards, quick answers, user reviews, and open discussion without leaving the page.

Tools, comparisons & answers

Explore the best next step before choosing ArteraAI

Browse similar tools, open focused comparison cards, and answer the most common buying questions.

Similar tools Comparisons FAQ
Compare

Compare alternatives

See how ArteraAI compares with the closest relevant AI tools.

Build custom comparison
Smart AI comparison ArteraAI vs Freed Compare pricing, ratings, features, AI score, and use cases. Paid alternative View comparison Smart AI comparison ArteraAI vs Hippocratic AI Compare pricing, ratings, features, AI score, and use cases. Enterprise only alternative View comparison Smart AI comparison ArteraAI vs Ada Compare pricing, ratings, features, AI score, and use cases. Freemium alternative View comparison Smart AI comparison ArteraAI vs Buoy Compare pricing, ratings, features, AI score, and use cases. paid alternative View comparison
Answers

Frequently asked questions

ArteraAI develops multimodal AI tests that analyze digital pathology images and patient data to provide prognostic and predictive insights for prostate cancer care. Its clinical reports support risk assessment and treatment discussions within qualified oncology workflows.
Oncology teams using AI-supported prostate cancer treatment planning
The listed pricing model for ArteraAI is Enterprise only. Pricing can change, so users should verify the latest plan details on the official website.
Yes. The current profile indicates that a free trial is available.
Community proof

User reviews

Real user feedback helps others understand strengths, limitations, and the best-fit workflows before choosing this tool.

No reviews Average rating
0 Total reviews
No reviews yet

Be the first to review ArteraAI

Share what worked, what did not, who this AI tool is best for, and what buyers should verify before choosing it.

Ask in discussion
Tool discussion

Ask or discuss this tool

Ask questions, share workflows, or discuss your experience with this AI tool.

ReplyContinue threads
EditUpdate your posts
ReportKeep it useful
0Total messages
0Threads
0Replies
Start a useful threadAsk, compare workflows, or reply to reviews

Keep it specific and helpful. You can edit or delete your own messages after posting.

Please log in to join the discussion.

Live discussion

Community messages

Reply to messages and keep the discussion useful. Use Report for abuse or spam. Your own posts can be edited or deleted.

No discussion yetBe the first to ask a question or share a useful workflow.